UTIs in at-risk patients: Are they 'complicated'?

Infections in Medicine

Volumn 16, Issue 8, 1999, Pages 533-540

  McCue, Jack D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ST MARY S MEDICAL CENTER   (United States)

Author keywords

Complicated UTI; Urinary catheters; Urinary tract infection

Indexed keywords

AMOXICILLIN; CIPROFLOXACIN; COTRIMOXAZOLE; LEVOFLOXACIN; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; TROVAFLOXACIN;

ANTIBIOTIC THERAPY; COMORBIDITY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; HUMAN; MENOPAUSE; PROSTATE HYPERTROPHY; REVIEW; TREATMENT PLANNING; URINALYSIS; URINARY TRACT INFECTION; URINARY TRACT MALFORMATION; URINE CULTURE; URINE INCONTINENCE; VESICOURETERAL REFLUX;

EID: 0032825161     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Falagas ME, Gorbach SL. Practice guidelines: urinary tract infections. Infect Dis Clin Pract. 1995;4:241-257.
2. Stamm WE, Hooton TM. Management of urinary tract infection in adults. N Engl J Med. 1993;329:1328-1334.
3. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997;11:551-580.
4. Hooton TM, Scholes D, Hughes JP, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med. 1996;335:468-474.
5. Bran JL, Levison ME, Kaye D. Entrance of bacteria into the female urinary bladder. N Engl J Med. 1972;286:626-629.
6. Abbott GD. Neonatal bacteriuria: a prospective study in 1460 infants. Br Med J. 1972;1: 267-269.
7. Herzog LW. Urinary tract infections and circumcision. Am J Dis Child. 1989;143:348-350.
8. Randolph MF, Greenfield M. The incidence of asymptomatic bacteriuria and pyuria in infancy. A study of 400 infants in private practice. J Pediatr. 1964;65:57-59.
9. Gillenwater JY, Harrison RB, Kunin CM. Natural history of bacteriuria in school girls: a long-term case-control study. N Engl J Med. 1979;301:369-371.
10. Sanford JP. Urinary tract symptoms and infections. Annu Rev Med. 1975;26:485-490.
11. Patton JP, Nash DB, Abrutyn E. Urinary tract infection: economic considerations. Med Clin North Am. 1991;75:495-513.
12. Nicolle LE. Urinary tract infection in the institutionalized elderly. Infect Dis Clin Pract. 1992;1:68-71.
13. McCue JD. Urinary tract infections in the elderly. Pharmacother. 1993;13(suppl):51S-53S.
14. Boscia JA, Levison ME, Abrutyn E, et al. Pyuria and asymptomatic bacteriuria in elderly ambulatory women. Ann Intern Med. 1989;110:404-405.
15. McCue JD. Gram-negative bacteremia in the elderly: incidence, ecology, etiology, and mortality. J Am Geriatr Soc. 1987;35:213-218.
16. Gleckman R, Blagg N, Hilbert D, et al. Acute pyelonephritis in the elderly. South Med J. 1982;75:551-554.
17. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329:753-756.
18. Brandenberg A, Mellstrom D, Samside G. Low dose oral estriol treatment in elderly women with urogenital infections. Acta Obstet Gynecol Scand. 1987;140(suppl):33-38.
19. Parsons CC, Schmidt JD. Control of recurrent lower urinary tract infection in the post-menopausal woman. J Urol. 1982;129:1224-1226.
20. Orlander JD, Jick SS, Dean AD, et al. Urinary tract infections and estrogen use in older women. J Am Geriatr Soc. 1992;40:817-820.
21. Klutke JJ, Bergman A. Hormonal influence on the urinary tract. Urol Clin North Am. 1995; 22:629-639.
22. Van Geelen JM, Doesburg WH, Thomas CMG, et al. Urodynamic studies in the normal menstrual cycle: the relationship between hormonal changes in the menstrual cycle and urethral pressure profiles. Am J Obstet. 1981;141:384-392.
23. Tapp AJS, Cardozo LD. The postmenopausal bladder. Br J Hosp Med. 1986;35:20-23.
24. McCallin PE, Stewart Taylor E, Whitehead RW. A study of the changes in cytology of the urinary sediment during the menstrual cycle and pregnancy. Am J Obstet Gynecol. 1950;60: 64-74.
25. Solomon C, Panagotopoulous P, Oppenheim A. Urinary cytology studies as an aid to diagnosis. Am J Obstet Gynecol. 1958;76:57-62.
26. Rud T, Anderson KE, Asmussen M, et al. Factors maintaining the urethral pressure in women. Invest Urol. 1980;17:343-347.
27. Baldassarre JS, Kaye D. Special problems of urinary tract infection in the elderly. Med Clin North Am. 1991;75:375-390.
28. Mims AD, Norman DC, Yamamura RH, et al. Clinically inapparent (asymptomatic) bacteriuria in ambulatory elderly men: epidemiologic, clinical and microbiological findings. J Am Geriatr Soc. 1990;38:1209-1214.
29. Boscia JA, Kobasa WD, Knight RA, et al. Epidemiology of bacteriuria in an elderly ambulatory population. N Engl J Med. 1986; 309:1420-1425.
30. Nicolle LE, Henderson E, Bjornson J, et al. The association of bacteriuria with resident characteristics in elderly institutionalized men. Ann Intern Med. 1987;106:682-686.
31. Nicolle LE, Bjornson J, Harding GKM, et al. Bacteriuria in elderly institutionalized men. N Engl J Med. 1983;309:1420-1425.
32. Orr PH, Nicolle LE, Duckworth RN, et al. Febrile urinary infection in the institutionalized elderly. Am J Med. 1996;100:71-77.
33. Lipsky BA. Urinary tract infections in men. Ann Intern Med. 1989;110:138-150.
34. Sobel JD. Pathogenesis of urinary tract infections. Host defenses. Infect Dis Clin North Am. 1987;1:751-772.
35. Barnes RC, Daifuku R, Roddy RE, et al. Urinary tract infection in sexually active homosexual men. Lancet. 1986;1:171-173.
36. Wong ES, Stamm WE. Sexual acquisition of urinary tract infection in a man. JAMA. 1983;250:3087-3088.
37. Bailey RR, Peddie BA, Swanson CP, et al. Sexual acquisition of urinary tract infection in a man. Nephron. 1986;44:217-218.
38. Spach DH, Stapleton AE, Stamm WE. Lack of circumcision increases the risk of urinary tract infection in young men. JAMA. 1992;267:679-681.
39. Wolfson SA, Kalmanson GM, Rubin ME, et al. Epidemiology of bacteriuria in a predominantly geriatric male population. Am J Med Sci. 1965;250:167-173.
40. Gleckman R, Crowley M, Natsios GA. Therapy of recurrent invasive urinary tract infections of men. N Engl J Med. 1979;301:878-880.
41. Smith JW, Jones SR, Reed WP, et al. Recurrent urinary tract infections in men: characteristics and response to therapy. Ann Intern Med. 1979;91:544-548.
42. Freeman RB, Smith WM, Richardson JA, et al. Long-term therapy for chronic bacteriuria in men: US Public Health Service cooperative study. Ann Intern Med. 1975;83:133-140.
43. Pead L, Maskell R. Urinary tract infection in adult men. J Infect. 1981;3:71-78.
44. Booth CM, Whiteside CG, Milroy EJG, et al. Unheralded urinary tract infection in the male: a clinical and urodynamic assessment. Br J Urol. 1981;53:270-273.
45. Sabbaj J, Hoagland VL, Cook T. Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men. Scand J Infect Dis. 1986;48(suppl):48-53.
46. Schaeffer AJ. Urinary tract infections in urology: a urologist's view of chronic bacteriuria. Infect Dis Clin North Am. 1987;1:875-892.
47. Ronald AR. Current concepts in the management of urinary tract infections in adults. Med Clin North Am. 1984;68:335-349.
48. Corrado ML, Grad C, Sabbaj J. Norfloxacin in the treatment of urinary tract infections in men with and without identifiable urologic complications. Am J Med. 1987;82(suppl 6B): 53-58.
49. Gleckman R, Crowley M, Natsios GA. Recurrent urinary tract infections in men: an assessment of contemporary treatment. Am J Med Sci. 1980;279:31-36.
50. Kunin CM. Long-term therapy of urinary tract infections. Ann Intern Med. 1975;83:273-274.
51. Preheim LC. Complicated urinary tract infections. Am J Med. 1985;79:62-66.
52. Anderson RU. Urinary tract infections in compromised hosts. Urol Clin North Am. 1986;13:727-734.
53. Bailey RR. Single-dose therapy for uncomplicated urinary tract infections. N Z Med J. 1985;98:327-329.
54. Sheehan G, Harding GKM, Ronald AR. Advances in the treatment of urinary tract infection. Am J Med. 1984;76:141-147.
55. Ronald AR, Conway B, Zhanel GG. The value of single-dose therapy to diagnose the site of urinary infection. Chemotherapy. 1990;36 (suppl 1):2-9.
56. Bailey RR. Management of lower urinary tract infections. Drugs. 1993;45(suppl 3):139-144.
57. Greenberg RN, Reilly PM, Luppen KL, et al. Randomized study of single-dose, three-day, and seven-day treatment of cystitis in women. J Infect Dis. 1986;153:277-282.
58. Stamm WE. Controversies in single dose therapy of acute uncomplicated urinary tract infections in women. Infection. 1992;20(suppl 4):272-275.
59. Ronald AR, Nicolle LE, Harding GKM. Single dose treatment failure in women with acute cystitis. Infection. 1992;209(suppl 4):276-279.
60. Thomas VL, Forland M. Antibody-coated bacteria in urinary tract infections. Kidney Int. 1982;21:1-7.
61. Buckwold FJ, Ludwig P, Harding GKM, et al. Therapy for acute cystitis in adult women. Randomized comparison of single-dose sulfisoxazole vs trimethoprim-sulfamethoxazole. JAMA. 1982;247:1839-1842.
62. Greenberg RN, Sanders CV, Lewis AC, et al. Single-dose cefaclor therapy of urinary tract infection. Evaluation of antibody-coated bacteria test and C-reactive protein assay as predictors of cure. Am J Med. 1981;71:841-845.
63. Kirn ED, Schaeffer AJ. Antimicrobial therapy for urinary tract infections. Semin Nephrol. 1994;14:551-569.
64. Basista MP. Randomized study to evaluate efficacy and safety of ofloxacin vs trimethoprim and sulfamethoxazole in treatment of uncomplicated urinary tract infection. Urology. 1991;37(suppl):21-27.
65. Norrby SR. Short-term treatment of uncomplicated lower urinary tract infections in women. Rev Infect Dis. 1990;12:458-467.
66. Stamm WE, Isselbacher KJ, Braunwald E, et al, eds. Harrison's Principles of Infernal Medicine. 13th ed. New York: McGraw-Hill; 1994: 548-554.
67. Cox CE, Serfer HS, Mena HR, et al. Ofloxacin versus trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infection. Clin Ther. 1992;14:446-457.
68. Stamm WE. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med. 1991;91(suppl 3b):65-71.
69. Daifuku R, Stamm W. Association of rectal and urethral colonization with urinary tract infection in patients with indwelling catheters. JAMA. 1984;252:2028-2030.
70. Platt R, Polk BF, Murdock B, et al. Risk factors for nosocomial urinary tract infection. Am J Epidemiol. 1986;124:977-985.
71. Platt R, Polk BF, Murdock B, et al. Mortality associated with nosocomial urinary tract infection. N Engl J Med. 1982;307:637-642.
72. Mobley HLT, Warren JW. Urease-positive bacteriuria and obstruction of long-term catheters. J Clin Microbiol. 1987;25:2216-2217.
73. Nickel JC, Ruseka I, Wright JB, et al. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother. 1985;27:619-624.
74. Stark RP, Maki DG. Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant? N Engl J Med. 1984; 311:560-564.
75. Kunin CM. Urinary tract infections in females. Clin Infect Dis. 1994;18:1-12.
76. McCue JD. Complicated, recurrent, and geriatric UTI. Patient Care.1994;(suppl):10-16.
77. McCue JD. Once-daily administration of lomefloxacin for infections in older patients: a summary of worldwide controlled clinical trials. Drugs. 1993;45(suppl 3):435-436.
78. Sobel JD, Kaye D, Mandell GL, et al, eds. Principles and Practice of Infections Diseases. 4th ed. New York: Churchill Livingstone; 1995: 662-689.
79. Stamm WE, Gorbach SL, Bartlett JG, et al, eds. Infectious Diseases. Philadelphia: WB Saunders; 1992:788-798.
80. Malverni R, Glauser MP. Comparative studies of fluoroquinolones in the treatment of urinary tract infections. Rev Infect Dis. 1988;10 (suppl 1):153-163.
81. Naber KG. Use of quinolones in urinary tract infections and prostatitis. Rev Infect Dis. 1989; 11(suppl 5):1321-1337.
82. Hooper DC, Wolfson JSE, Hooper DC, et al, eds. Quinolone Antimicrobial Agents. 2nd ed. Washington, DC: American Society for Microbiology; 1993.
83. Sanders WE, Sanders CC, eds. Fluoroquinolones in the Treatment of Infectious Diseases. Glenview, Ill: Physicians & Scientists Publishing; 1990.
84. Hooper DC, Wolfson JS. Fluoroquinolone antimicrobial agents. N Engl J Med. 1991;324: 384-394.
85. Johnson JR, Stamm WE. Diagnosis and treatment of acute urinary tract infections. Infect Dis Clin North Am. 1987;1:773-791.